Long-term CVS Health shareholders are being encouraged to review their positions as the firm evaluates potential breaches of oversight responsibilities. According to attorneys Daniel Sadeh and Zachary Halper, the investigation focuses on whether corporate management failed in its duty to protect investor interests, a move that could lead to court-approved financial awards or systemic changes to company policies.

Investors currently holding stock in the company may be entitled to seek the return of funds or the implementation of stricter accountability mechanisms. The firm operates on a contingent fee basis, meaning participants face no out-of-pocket expenses for legal representation. Those looking to discuss their rights or the scope of the investigation are directed to contact the firm’s Manhattan office at One World Trade Center.